Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis

BACKGROUND: Recent evidence has indicated that alterations in energy metabolism play a critical role in the pathogenesis of fibrotic diseases. Studies have suggested that ‘metabolic reprogramming’ involving the glycolysis and oxidative phosphorylation (OXPHOS) in cells lead to an enhanced generation...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantanhede, Isabella Gomes, Liu, Huan, Balbuena Rodriguez, Vestaen, Shiwen, Xu, Ong, Voo H., Denton, Christopher P., Ponticos, Markella, Xiong, Guo, Lima-Filho, José Luiz, Abraham, David, Abu-Hanna, Jeries, Taanman, Jan-Willem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592691/
https://www.ncbi.nlm.nih.gov/pubmed/36304460
http://dx.doi.org/10.3389/fimmu.2022.1004949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592691/
https://www.ncbi.nlm.nih.gov/pubmed/36304460
http://dx.doi.org/10.3389/fimmu.2022.1004949

Ejemplares similares